U.S. Health Officials Halt Study on COVID-19 Vaccine Effectiveness

NEW YORK — Health officials in the U.S. have decided to stop the release of a study examining whether the COVID-19 vaccine effectively reduces hospitalization rates among adults. This decision was confirmed by a spokesman from the Department of Health and Human Services, who mentioned a disagreement regarding the study’s methodology.

The research was meant to be published in the Morbidity and Mortality Weekly Report, which is the Centers for Disease Control and Prevention’s primary publication. Typically, studies assess the effectiveness of the COVID-19 vaccine by looking at hospitalized patients or those visiting emergency rooms. Researchers evaluate vaccination status and then compare COVID-19 positive test rates between vaccinated and unvaccinated individuals.

Similar studies using this approach have successfully been published in reputable journals like Pediatrics and the New England Journal of Medicine.

This new study reportedly found that the vaccine halved emergency room visits and hospitalizations among generally healthy adults during the previous winter, as first reported by The Washington Post.

HHS officials did not specify the exact issues with the study’s methodology, but they suggested that factors like previous infections, patient behavior, and differences in who seeks medical care could influence the results.

However, many in the scientific community do not share these concerns. Dr. Fiona Havers, who previously worked at the CDC, argued that the methodology accounts for variations in care-seeking behavior, and prior infections should not be a significant obstacle, given that many Americans have contracted the virus.

No study design is flawless, yet HHS hasn’t put forth a viable alternative for obtaining timely data on the vaccines’ effectiveness, according to Havers, who headed a CDC surveillance team focused on COVID-19 and other respiratory diseases.

During Donald Trump’s initial term as president, there were worries among public health advocates about political influence over published research. Those concerns resurfaced last year when the publication of the MMWR was temporarily halted. Although it resumed, some argue that it has become a less comprehensive resource than before.

“Health care professionals depend on the MMWR for accurate information regarding public health issues,” remarked U.S. Senator Dick Durbin, a Democrat from Illinois, who expressed concerns about the CDC’s communication last year.

“Silencing scientists and healthcare professionals on critical preventive measures can be detrimental. The CDC must not impose political restrictions on essential research,” Durbin stated on Wednesday.